Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM50J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,614
Award facts
- Contract value 100% obligated
- $24,613.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,613.84 to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes (0.5ML) with a firm fixed price structure. The contract, awarded on January 30, 2026, with an ultimate completion date of February 2, 2026, is a non-set-aside award issued under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in Pennsylvania. The company operates as a subsidiary of Cencora, Inc., which holds the parent indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
This delivery order represents a task order issued under the larger DLA pharmaceutical supply contract vehicle, which provides comprehensive global pharmaceutical support to military healthcare systems, the Defense Health Agency, and other federal medical institutions. GARDASIL 9 is a widely used vaccine distributed through federal medical procurement channels to support immunization programs across military treatment facilities and veteran healthcare systems. The firm fixed pricing and accelerated completion timeline reflect the routine nature of this pharmaceutical supply delivery within the DLA's broader medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FM50J?
SPE2DR26FM50J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FM50J worth?
The government has obligated $24,614 on SPE2DR26FM50J.
Is contract SPE2DR26FM50J an order under another contract?
Yes. SPE2DR26FM50J is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM50J competed?
The extent of competition for SPE2DR26FM50J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award